Oncology
Cancer is the second leading cause of mortality, attributed to one out of every five adult deaths. Tumor markers provide useful information for risk assessment, detection, diagnosis, prognosis and monitoring of cancer patients. Siemens Healthcare Diagnostics’ product portfolio provides multiple diagnostic platforms with which to evaluate a patient’s condition.
Associated Systems
Immunoassay
Related Technical Documents
IMMULITE Tumor Marker Assays: Multicenter Reference Range Data: 4th Edition
Download[1.05 MB]
BR-MA, GI-MA, and OM-MA: Immunoassays for the Tumor Markers CA15-3, CA19-9, and CA125.
Download[249 KB]
HCG and Subunits: DPC Assay Specificities and Clinical Utility in Obstetrical Care and Oncology
Download[61 KB]
Thyroglobulin and Antithyroglobulin Autoantibodies in Differentiated Thyroid Cancer
Download[62 KB]
Articles of Interest
Related References
Witherspoon LR.Early detection of cancer relapse after prostatectomy using very sensitive prostate-specific antigen measurements. Brit J Urol 1996;79 Suppl 1:82-6.
Witherspoon LR, Lapeyrolerie T.Sensitive prostate specific antigen measurements identify men with long disease-free intervals and differentiate aggressive from indolent cancer recurrences within 2 years after radical prostatectomy. J Urol 1997;157:1322-8.
Yu H, Diamandis EP, Prestigiacomo AF, Stamey TA. Ultrasensitive assay of prostate-specific antigen used for early detection of prostate cancer relapse and estimation of tumor-doubling time after radical prostatectomy. Clin Chem 1995;41:430-4.
Chan DW, Sell S. Tumor Markers. In: Tietz textbook of clinical chemistry. 3rd ed. Burtis CA, Ashwood ER, editors. Philadelphia: WB Saunders, 1999: 722-49.
Statland BE, Winkel P.Neoplasia. In: Clinical chemistry. 3rd ed. Kaplan LA, Pesce AJ, editors. St. Louis: Mosby, 1996: 983-1003.
| Tumor Markers |
ADVIA Centaur |
IMMULITE |
|---|---|---|
| AFP |
• |
• |
| BR-MA (CA15-3) |
|
• |
| BR27.29 |
• |
|
| CEA |
• |
• |
| CA15-3 |
• |
|
| CA125II |
• |
|
| CA19-9 |
• |
|
| HER-2/neu |
• |
|
| GI-MA (CA19-9) |
|
* |
| OM-MA (CA125) |
• |
|
| PAP |
|
• |
| PSA |
• |
• |
| cPSA |
• |
|
| Free PSA |
† |
* |
| Third Generation PSA |
• |
|
| TPS™ |
* |
Not all assays available on all platforms.
* Available outside the US; not available in the US
† Under development
